Back

Earlier surgery improves long-term survival compared to class I surgical indications and infective endocarditis surgery for isolated severe tricuspid regurgitation

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Cardiovascular Surgery ePosters Valves ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Tom Kai Ming Wang

Auckland City Hospital, Auckland (New Zealand)

22 More presentations in this session

Presentation thumbnail
Machine learning for risk prediction of in-hospital mortality in adult cardiac surgery
Doctor L. Myslivecek (Bristol, GB)
Abstract Slides
Presentation thumbnail
Outcomes after coronary artery bypass graft surgery: systematic review and meta-analysis comparing bilateral versus single internal thoracic artery grafts
Miss M. Stefil (Adelaide, AU)
Abstract Slides
Presentation thumbnail
Multiple vs single arterial grafting in coronary surgery among diabetic patients: a meta-analysis
Mr J. Leite-Moreira (Porto, PT)
Abstract Slides
Presentation thumbnail
Perioperative use of renin-angiotensin system inhibitors and short-term outcomes in patients undergoing cardiac surgery
Doctor T. Viana (Salvador, BR)
Abstract Slides
Presentation thumbnail
Long-term outcomes following coronary artery bypass grafting: the role of off-pump strategy
Doctor F. Barili (Milan, IT)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular Surgery ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Right ventricular function and systolic pressure effect on survival of patients with tricuspid regurgitation
28 August 2020
thumbnail
Congress Presentation
Optimal timing of surgery for patients with infective endocarditis
24 March 2023
thumbnail
Congress Session
Meet the Experts: mitral and tricuspid valve repair revisited: when to consider surgical or transcatheter approaches
26 August 2022
thumbnail
Congress Presentation
Earlier surgical myectomy vs. waiting for a Class I indication is associated with improved long-term survival in symptomatic hypertrophic obstructive cardiomyopathy patients
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources